Market Watch: Latest Articles
Pharma’s Capacity Illusion
Specialist pharma capacity remains constrained by format, qualification and demand
Pharma’s Manufacturing Reshuffle Is Feeding CDMO Growth
Commercial site transfers reshape CDMO growth, revenue timing and value
The CDMO Capacity Race Has Changed
CDMO competition shifts toward specialist capacity, geography and selective outsourcing
Cell & Gene Therapy Manufacturing: The Race to Scale
Manufacturing readiness now determines which cell and gene therapies scale
Beyond the Batch: Pharma Manufacturing Becomes Strategic
CDMOs become strategic partners as biologics complexity reshapes pharmaceutical manufacturing
Fill-Finish Manufacturing Is Now a Strategic Constraint
Fill-finish capacity now defines biologics launches, valuation strength, and competitive leverage
